CDKN2A and acute lymphoblastic leukemia: They successfully identified the CDKN2A rs3731249 polymorphism, which exhibited a 2% allele frequency in controls and was found to confer a three-fold increased risk of ALL in children of European ancestry as well as Hispanic children.